Edition:
United States

McKesson Corp (MCK)

MCK on New York Consolidated

150.28USD
20 Jan 2017
Change (% chg)

$2.99 (+2.03%)
Prev Close
$147.29
Open
$147.50
Day's High
$151.82
Day's Low
$147.50
Volume
3,076,859
Avg. Vol
2,478,574
52-wk High
$199.43
52-wk Low
$114.53

MCK

Chart for MCK

About

McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty... (more)

Overall

Beta: 1.06
Market Cap(Mil.): $33,976.35
Shares Outstanding(Mil.): 226.09
Dividend: 0.28
Yield (%): 0.75

Financials

  MCK Industry Sector
P/E (TTM): 16.87 19.71 39.27
EPS (TTM): 8.91 -- --
ROI: 10.71 12.08 59.22
ROE: 22.42 13.70 66.93

McKesson in record $150 mln U.S. settlement over suspicious drug orders

McKesson Corp, one of the largest U.S. distributors of pharmaceutical drugs, will pay a record $150 million to resolve a U.S. investigation into whether it failed to report suspicious orders of addictive painkillers.

Jan 17 2017

McKesson in record $150 million U.S. settlement over suspicious drug orders

McKesson Corp, one of the largest U.S. distributors of pharmaceutical drugs, will pay a record $150 million to resolve a U.S. investigation into whether it failed to report suspicious orders of addictive painkillers.

Jan 17 2017

UPDATE 1-McKesson in record $150 mln U.S. settlement over suspicious drug orders

Jan 17 McKesson Corp, one of the largest U.S. distributors of pharmaceutical drugs, will pay a record $150 million to resolve a U.S. investigation into whether it failed to report suspicious orders of addictive painkillers.

Jan 17 2017

REFILE-BRIEF-McKesson finalizes settlement with DOJ and DEA to resolve past claims

* McKesson finalizes settlement with U.S. Department of Justice and U.S. Drug enforcement administration to resolve past claims

Jan 17 2017

McKesson to pay record $150 mln settlement over suspicious drug orders -U.S.

WASHINGTON, Jan 17 McKesson Corp, one of the largest U.S. distributors of pharmaceutical drugs, has agreed to pay a record $150 million civil penalty for allegedly failing to report suspicious drug orders, the U.S. Justice Department said on Tuesday.

Jan 17 2017

Pharma's middlemen will feel the squeeze in 2017

NEW YORK (Reuters Breakingviews) - The pharmaceutical industry's middlemen face a 2017 clampdown. The U.S. medical system's opacity and complexity have stoked drug prices, fueling the flow of dollars to insurers, wholesalers and pharmacy benefit managers (PBMs). The growth of high-deductible insurance - primed to accelerate under the incoming Trump administration - will bring much-needed transparency to the market, and unaccustomed pressure on these firms.

Dec 30 2016

BRIEF-Celesio H1 adj EBIT down at 157.1 million euro

* EBIT (earnings before interest and taxes) for continuing operations saw a decrease of 36.0 per cent to 146.3 million euro ($155.77 million) in first half of fiscal 2017

Nov 22 2016

BRIEF-Medical Developments International says Trump's election will not negatively impact co

* Mckesson placed its first order for stock which will be delivered by end of december

Nov 13 2016

U.S. drug wholesaler shares tumble on pricing-war fears

NEW YORK Shares of the three major U.S. prescription drug wholesalers tumbled on Friday as investors feared a pricing war after McKesson Corp's quarterly report that rippled through the pharmaceutical supply chain.

Oct 28 2016

U.S. drug wholesaler shares tumble on pricing-war fears

NEW YORK, Oct 28 Shares of the three major U.S. prescription drug wholesalers tumbled on Friday as investors feared a pricing war after McKesson Corp's quarterly report that rippled through the pharmaceutical supply chain.

Oct 28 2016

Earnings vs. Estimates